Tri Pudy Asmarawati and Widodo and Mochammad Thaha and Aditiawardana and Nunuk Mardiana and Ardityo Rahmat Ardhany and Artaria Tjempakasari and Djoko Santoso and Pranawa and Chandra Irwanadi (2016) Comparison of Asymmetric Dimethylarginine Levels Between Stages Three, Four, and Five Non-dialysis of Chronic Kidney Disease. Acta Medica Indonesiana, 48 (1). pp. 28-34. ISSN 0125-9326
Text (Artikel)
Comparison of Asymmetric Dimethylarginine Levels Between Stages Three, Four, and Five Non-dialysis of Chronic Kidney Disease.pdf Download (305kB) |
|
Text (Peer Review)
Comparison of asymmetric.pdf Download (1MB) |
|
Text (Similarity)
Comparison of Asymmetric Dimethylarginine Levels Between Stages Three, Four, and Five Non-dialysis of Chronic Kidney Disease.pdf Download (2MB) |
|
Text (Bukti Korespondensi)
Kkorespondensi Comparison of Asymmetric.pdf Download (90kB) |
Abstract
Aim: to determine the differences of ADMA level between stages 3, 4, and 5 non-dialysis of chronic kidney disease (CKD) patients at Outpatient Nephrology Clinic, Dr. Soetomo Hospital. Methods: a cross-sectional study was conducted on stage 3, 4, and 5 non-dialysis CKD patients at Outpatient Nephrology Clinic, Dr. Soetomo Hospital, Surabaya from January to February 2015. Stages of CKD were determined based on GFR estimation according to 4-variable MDRD formula. Statistical analysis of differences in the levels of ADMA in three subject groups use one-way ANOVA test. Results:seventy-five patients were included in the study. Each group consisted of 25 patients stage 3, 4, and, 5 non-dialysis patients. Mean age of stage 3, stage 4, and stage 5 non-dialysis CKD patients were respectively 57.12 years, 54.80 years and 53.68 years. The mean levels of ADMA in stage 3, stage 4, and 5 were 0.62 (0.11) IU/mL, 0.72 (0.16) IU/mL, and 0.73 (0.18) IU/mL respectively. Analysis of the differences between the groups showed significant differences in ADMA levels (p=0.04), with the highest difference between stage 3 and stage 5. Conclusion:comparison of ADMA levels showed significant differences between CKD stages and the level tends to be higher along with increase severity of CKD stages.
Item Type: | Article | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Uncontrolled Keywords: | chronic kidney disease, asymmetric dimethylarginine (ADMA), cardiovascular disease | ||||||||||||||||||||||
Subjects: | R Medicine > R Medicine (General) R Medicine > RC Internal medicine |
||||||||||||||||||||||
Divisions: | 01. Fakultas Kedokteran > Ilmu Penyakit Dalam | ||||||||||||||||||||||
Creators: |
|
||||||||||||||||||||||
Depositing User: | arys fk | ||||||||||||||||||||||
Date Deposited: | 16 Feb 2021 02:22 | ||||||||||||||||||||||
Last Modified: | 15 Jun 2021 02:57 | ||||||||||||||||||||||
URI: | http://repository.unair.ac.id/id/eprint/103931 | ||||||||||||||||||||||
Sosial Share: | |||||||||||||||||||||||
Actions (login required)
View Item |